Salient Surgical Technologies Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $497M

Salient Surgical Technologies General Information

Description

Developer of mono-polar electrosurgical devices designed to treat liver and pancreatic resections. The company's Aquamantys System, a collection of surgical tools, is used to prevent blood loss by pre-coagulating parenchyma and vessels prior to transaction, enabling surgeons to use the devices across a range of surgical procedures including orthopaedic reconstruction, spine surgery, orthopaedic trauma and surgical oncology.

Contact Information

Website
www.salientsurgical.com
Formerly Known As
Tissuelink Medical, Tissuelink Medical Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 180 International Drive
  • Portsmouth, NH 03801
  • United States
+1 (800)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Acquirer
Medtronic
Vertical(s)
Oncology
Corporate Office
  • 180 International Drive
  • Portsmouth, NH 03801
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Salient Surgical Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 31-Aug-2011 $497M Completed Generating Revenue
9. Later Stage VC (Series G) 06-Jan-2010 Completed Generating Revenue
8. Later Stage VC (Series F) 16-Mar-2009 Completed Generating Revenue
7. IPO 26-Aug-2008 Cancelled Generating Revenue
6. Later Stage VC 14-Dec-2007 Completed Generating Revenue
5. Later Stage VC (Series E) 20-Mar-2007 Completed Generating Revenue
4. Later Stage VC (Series D) 31-Jan-2003 Completed Startup
3. Later Stage VC (Series C) 15-Jan-2002 Completed Startup
2. Early Stage VC (Series B) 16-Oct-2000 $19.6M $23.6M Completed Startup
1. Early Stage VC (Series A) 01-Aug-1999 $4M $4M Completed Startup
To view Salient Surgical Technologies’s complete valuation and funding history, request access »

Salient Surgical Technologies Former Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Affinity Capital Management Venture Capital Minority
Apothecary Capital Venture Capital Minority
Arnerich Massena Limited Partner Minority
Brait Holding Company Minority
Crescendo Ventures Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Ready to get started?

Request a free trial

Salient Surgical Technologies FAQs

  • When was Salient Surgical Technologies founded?

    Salient Surgical Technologies was founded in 1999.

  • Where is Salient Surgical Technologies headquartered?

    Salient Surgical Technologies is headquartered in Portsmouth, NH.

  • What industry is Salient Surgical Technologies in?

    Salient Surgical Technologies’s primary industry is Surgical Devices.

  • Is Salient Surgical Technologies a private or public company?

    Salient Surgical Technologies is a Private company.

  • What is the current valuation of Salient Surgical Technologies?

    The current valuation of Salient Surgical Technologies is .

  • What is Salient Surgical Technologies’s current revenue?

    The current revenue for Salient Surgical Technologies is .

  • How much funding has Salient Surgical Technologies raised over time?

    Salient Surgical Technologies has raised $121M.

  • Who are Salient Surgical Technologies’s investors?

    Affinity Capital Management, Apothecary Capital, Arnerich Massena, Brait, and Crescendo Ventures are 5 of 20 investors who have invested in Salient Surgical Technologies.

  • When was Salient Surgical Technologies acquired?

    Salient Surgical Technologies was acquired on 31-Aug-2011.

  • Who acquired Salient Surgical Technologies?

    Salient Surgical Technologies was acquired by Medtronic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process